Patents Assigned to Kedalion Therapeutics
  • Patent number: 11278448
    Abstract: Aspects of the invention include a device for fluid delivery to the ocular surface having a self-alignment system. The fluid delivery device includes a fluid package having a reservoir and one or more apertures, an actuator component configured to eject fluid from the reservoir through the one or more apertures and an image-based self-alignment system configured to align fluid ejected through the one or more apertures with a target location on the eye of a user. Also provided are methods of using the devices in fluid delivery applications, as well as a kit that includes components of the devices.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: March 22, 2022
    Assignee: Kedalion Therapeutics, Inc.
    Inventors: Daniel Palanker, Mark Blumenkranz, Ehud Ivri, Reynaldo Quintana
  • Patent number: 10888454
    Abstract: Fluid delivery devices and methods are described, where the device may comprise a piezoelectric actuator operatively coupled to an ampoule with fluid, under a preloading force. The ampoule may comprise a thin-walled thermoplastic package which includes one or more apertures positioned on the wall of the ampoule. The piezoelectric actuator may be configured to clamp at least partially around the circumference of the ampoule and apply oscillations to its wall. The oscillations, typically in ultrasonic frequency, produce cycles of acoustic pressure in the fluid, leading to ejection of the fluid droplets or streams from the apertures.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: January 12, 2021
    Assignee: Kedalion Therapeutics, Inc.
    Inventors: Yehuda Ivri, Mark Blumenkranz, Daniel V. Palanker
  • Patent number: 10624781
    Abstract: Micro-droplet delivery devices and methods are described where the device may comprise a piezoelectric actuator having a piezoelectric chip that is operatively coupled to a drug package under a preloading force. The actuator is configured to generate an acoustic pressure within the drug package to dispense droplets of an agent from an aperture, e.g., to the corneal surface of the eye. The piezoelectric actuator can be coupled or decoupled from the drug package.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: April 21, 2020
    Assignee: Kedalion Therapeutics, Inc.
    Inventor: Yehuda Ivri
  • Patent number: 10583038
    Abstract: Fluid delivery devices and methods are described where the device may comprise a piezoelectric actuator having a piezoelectric chip that is operatively coupled to a drug package under a preloading force. The actuator is configured to generate an acoustic pressure within the drug package to dispense droplets or a continuous stream of an agent from an aperture, e.g., to the corneal surface of the eye. The piezoelectric actuator can be coupled or decoupled from the drug package via a coupling mechanism which enables the quick release and consistent securement of the drug package to the actuator and housing.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: March 10, 2020
    Assignee: Kedalion Therapeutics
    Inventor: Yehuda Ivri